StonvexLoading…
StonvexStonvexStonvexCore line items from BKTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-12 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $23.05M | $21.29M | $86.14M | $64.63M | $40.22M |
Operating Income | Not available | $3.29M | $15.99M | $11.76M | $6.91M |
Net Income | Not available | $2.76M | $13.54M | $9.31M | $3.74M |
EPS (Diluted) | $0.89 | $0.69 | $3.44 | $2.38 | $1.51 |
Total Assets | Not available | $68.78M | $63.76M | $66.86M | $60.43M |
Total Liabilities | Not available | $21.06M | $19.06M | $25.91M | $23.66M |
Cash & Equivalents | Not available | $28.98M | $22.79M | $21.47M | $11.85M |
Free Cash Flow OCF − CapEx | Not available | $6.36M | $18.40M | $15.56M | $5.48M |
Shares Outstanding | Not available | 3.74M | 3.73M | 3.74M | 3.69M |